Akebia Therapeutics (AKBA) Reports Q4 EPS of $0.25, Beats on Revenues
Go back to Akebia Therapeutics (AKBA) Reports Q4 EPS of $0.25, Beats on Revenues| AKEBIA THERAPEUTICS (NASDAQ: AKBA) | Delayed: 0.92 +0.02 (2.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.90 | 52 Week High | $13.20 | |||
| Open | $0.89 | 52 Week Low | $7.00 | |||
| Day High | $0.93 | P/E | N/A | |||
| Day Low | $0.88 | EPS | $0.00 | |||
| Volume | 7,372,563 | |||||
